Pilot Projects Program Core
Pilot Projects Program Core
批准号:
10438749
负责人:
Heloise. ANNE Pereira
金额:
$56.24万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2023-08-15
关键词:
AddressAffectAmerican IndiansArthritisAutoimmunityAwardBasic ScienceCardiovascular DiseasesCardiovascular systemCategoriesCessation of lifeClinicalClinical ResearchClinical SciencesCommunitiesCommunity DevelopmentsCommunity OutreachCountryCountyCritiquesDevelopmentDiabetes MellitusDiagnosisDiseaseEnvironmentEvaluationExtramural ActivitiesFacultyFeedbackFemaleFinancial SupportFosteringFoundationsFundingFunding AgencyFunding OpportunitiesFutureGenerationsGoalsGrantGrowth and Development functionHealthHealth BenefitHealth PrioritiesHoward Temin AwardIndividualInfrastructureInstitutionLeadershipLife ExpectancyMalignant NeoplasmsMedical ResearchMentorsMentorshipMinority GroupsMissionModelingObesityOklahomaOutcomePatientsPersonal SatisfactionPhase TransitionPilot ProjectsPopulationPrevalencePrincipal InvestigatorProgram SustainabilityPublishingResearchResearch DesignResearch PersonnelResearch PriorityResearch Project GrantsResearch SupportResourcesRural PopulationScientistSecureServicesSeverity of illnessSourceStructureTalentsTestingTobacco useTrainingTranslatingTranslational ResearchTribesUnderrepresented MinorityUnderrepresented PopulationsUnited States National Institutes of HealthWritingbridge programcare providerscareercareer developmentclinical careclinical developmentclinical infrastructurecommunity engaged researchcommunity engagementdisabilityhealth disparityimprovedinnovationmedical schoolsmeetingsmultidisciplinarynovelopioid abusepractical applicationpreventprogramsresponserural dwellerssuccesstranslational research programtribal institution
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Despite recent improvements, Oklahoma continues to have high rates of tobacco use, obesity, cancer deaths,
and cardiovascular deaths, arthritis disability and an opioid abuse crisis. The mission of the OSCTR Pilot
Projects Program (PPP) is to accelerate discoveries into Oklahoma's health priorities by fostering innovative
and collaborative clinical and translational research (CTR) projects, leading to nationally and federally funded
independent research programs. Our current pilot program has received 169 applications and funded 28 with
>50% female and 37.5% of these PIs from under-represented minority populations. These pilot recipients have
been immensely successful garnering a total of $17.2 M of PI-level extramural funding to these new
investigators or a $7.60 ROI. To do this the PPP provides pilot project funding (Aim 1), coordinates
infrastructure support and mentoring for pilot investigators (Aim 2), and identifies promising but unfunded junior
investigators for additional mentoring (Aim 3). This strategy is built on the hypothesis that providing junior
investigators with CTR funding, infrastructure, and mentorship will coalesce a new generation of well-trained,
well-funded CTR scientists equipped to translate scientific discoveries into improved clinical care and patient
well-being. In all of these functions, the PPP prioritizes research that addresses prominent health issues in
Oklahoma and other IDeA states. To build on these early successes, maintain this dramatically different new
trajectory for OSCTR new investigators and in response to Evaluation Core and EAC feedback, the PPP has
expanded from one to three award types. CTR Pilot Awards, as previous, provide 12 months of funding for at
least five novel research projects per year. To address the need for interim support while analyzing, publishing,
and seeking extramural funding for pilot projects, competitive Pilot Sustainability Bridge Awards will provide 6
additional months of funding for up to 3 pilot recipients per year. Finally, to better support the unique needs of
our partners, the Community-Engaged Research Exploratory Awards provide 6 months of funding for projects
initiating new partnerships with non-academic institutions, such as tribal institutions, community development
agencies, county health improvement organizations, health departments, and primary care providers. In
addition to these OSCTR-funded awards, the PPP leverages other local funding programs when possible to
provide larger or additional awards in each category. Beyond providing financial support, the PPP provides an
environment that nurtures the continued success of these junior investigators. Upon funding, the Pilot Kickoff
Meeting introduces awardees to the OSCTR Cores, Directors, and other awardees, and helps them critique
each other's proposals. Throughout the award, investigators will receive structured mentoring (Professional
Development Core) and training in scientific writing to foster career development and growth toward
independence. The PPP assists current and past awardees, as well as promising but unfunded applicants, to
identify additional funding sources and develop a strategy for securing independent, national funding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Ophthalmic Product for Corneal Infections and Injuries
-
批准号:10156366
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2021
-
负责人:Heloise. ANNE Pereira
-
依托单位:
50th Annual Meeting of the Society for Leukocyte Biology (SLB). Leukocyte Memory: Health and Disease
-
批准号:9398529
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2017
-
负责人:Heloise. ANNE Pereira
-
依托单位:
48th Annual Meeting of the Society for Leukocyte Biology - Immunity in Health and Disease
-
批准号:8986501
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2015
-
负责人:Heloise. ANNE Pereira
-
依托单位:
Pilot Projects Program Core
-
批准号:10218190
-
项目类别:
-
资助金额:$55.09万
-
财政年份:2013
-
负责人:Heloise. ANNE Pereira
-
依托单位:
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
-
批准号:7324392
-
项目类别:
-
资助金额:$71.39万
-
财政年份:2007
-
负责人:Heloise. ANNE Pereira
-
依托单位:
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
-
批准号:8142110
-
项目类别:
-
资助金额:$71.05万
-
财政年份:2007
-
负责人:Heloise. ANNE Pereira
-
依托单位:
CAP37 and ocular inflammation
-
批准号:8135325
-
项目类别:
-
资助金额:$35.16万
-
财政年份:2007
-
负责人:Heloise. ANNE Pereira
-
依托单位:
CAP37 and ocular inflammation
-
批准号:7500044
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2007
-
负责人:Heloise. ANNE Pereira
-
依托单位:
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
-
批准号:7925577
-
项目类别:
-
资助金额:$67.74万
-
财政年份:2007
-
负责人:Heloise. ANNE Pereira
-
依托单位:
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
-
批准号:7686124
-
项目类别:
-
资助金额:$71.73万
-
财政年份:2007
-
负责人:Heloise. ANNE Pereira
-
依托单位:
CAP37 and ocular inflammation
-
批准号:7679434
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2007
-
负责人:Heloise. ANNE Pereira
-
依托单位:
CAP37 and ocular inflammation
-
批准号:7322473
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2007
-
负责人:Heloise. ANNE Pereira
-
依托单位:
CAP37 and ocular inflammation
-
批准号:7908764
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2007
-
负责人:Heloise. ANNE Pereira
-
依托单位:
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
-
批准号:7492260
-
项目类别:
-
资助金额:$59.27万
-
财政年份:2007
-
负责人:Heloise. ANNE Pereira
-
依托单位:
MONOCYTE SPECIFIC CHEMOATTRACTANT
-
批准号:2697490
-
项目类别:
-
资助金额:$17.79万
-
财政年份:1990
-
负责人:Heloise. ANNE Pereira
-
依托单位:
MONOCYTE SPECIFIC CHEMOATTRACTANT FROM HUMAN PMN
-
批准号:6341603
-
项目类别:
-
资助金额:$21.44万
-
财政年份:1990
-
负责人:Heloise. ANNE Pereira
-
依托单位:
MONOCYTE-SPECIFIC CHEMOATTRACTANT FROM HUMAN PMN
-
批准号:2064233
-
项目类别:
-
资助金额:$15.14万
-
财政年份:1990
-
负责人:Heloise. ANNE Pereira
-
依托单位:
MONOCYTE-SPECIFIC CHEMOATTRACTANT FROM HUMAN PMN
-
批准号:3142326
-
项目类别:
-
资助金额:$14.72万
-
财政年份:1990
-
负责人:Heloise. ANNE Pereira
-
依托单位:
MONOCYTE SPECIFIC CHEMOATTRACTANT FROM HUMAN PMN
-
批准号:6337483
-
项目类别:
-
资助金额:$1.68万
-
财政年份:1990
-
负责人:Heloise. ANNE Pereira
-
依托单位:
MONOCYTE-SPECIFIC CHEMOATTRACTANT FROM HUMAN PMN
-
批准号:3142327
-
项目类别:
-
资助金额:$14.02万
-
财政年份:1990
-
负责人:Heloise. ANNE Pereira
-
依托单位:
海外基金